Share Price and Basic Stock Data
Last Updated: February 1, 2026, 10:02 pm
| PEG Ratio | 0.27 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bhaskar Agrochemicals Ltd operates in the agrochemicals and pesticides sector, offering a range of products that cater to agricultural needs. The company’s stock price stood at ₹107, with a market capitalization of ₹55.7 Cr. Over the years, Bhaskar Agrochemicals has shown a fluctuating revenue trend, with reported sales of ₹55 Cr in March 2023, increasing to ₹91 Cr by March 2025. The trailing twelve months (TTM) revenue reached ₹110 Cr, indicating a healthy growth trajectory. Quarterly sales fluctuated significantly, with a low of ₹7.33 Cr in June 2023, rebounding to ₹29.55 Cr by September 2023. This volatility may be attributed to seasonal demand, but the overall annual growth signals a robust market presence. The company’s operating profit margin (OPM) was recorded at 13.10%, reflecting an effective cost management strategy in an industry often characterized by thin margins. The increasing sales and positive OPM illustrate Bhaskar Agrochemicals’ ability to capitalize on market opportunities while managing operational expenses effectively.
Profitability and Efficiency Metrics
Bhaskar Agrochemicals reported a net profit of ₹6 Cr for the fiscal year ending March 2025, translating to an earnings per share (EPS) of ₹7.48. The company’s return on equity (ROE) stood at 24.7%, indicating a strong ability to generate returns for shareholders relative to equity. The return on capital employed (ROCE) recorded at 21.3% further underscores the company’s efficient use of capital in generating profits. However, the company faced challenges in the last few quarters, notably posting negative operating profits in both March and June 2023, which raised concerns about operational stability. The cash conversion cycle (CCC) increased to 155 days, suggesting potential inefficiencies in managing receivables and inventory. While the interest coverage ratio (ICR) of 4.56x demonstrates a solid capacity to cover interest expenses, the company must address the prolonged CCC to enhance liquidity and operational efficiency.
Balance Sheet Strength and Financial Ratios
Bhaskar Agrochemicals’ balance sheet reflects a mix of strengths and vulnerabilities. The total liabilities stood at ₹58 Cr as of March 2025, with borrowings at ₹20 Cr, indicating a manageable level of debt relative to equity. The total debt-to-equity ratio was recorded at 1.07x, which is relatively stable compared to industry norms. The company’s reserves have shown consistent growth, rising to ₹13 Cr in March 2025, which provides a buffer for future investments and operational challenges. The book value per share increased to ₹34.07, reflecting the company’s asset base growth. However, the current ratio of 1.20x indicates a potential liquidity concern, as it is barely above the threshold of 1, suggesting that the company should improve its current asset management. Overall, while the balance sheet displays solid equity growth and manageable debt levels, attention to liquidity ratios is essential for future resilience.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bhaskar Agrochemicals reveals a stable ownership structure, with promoters holding 62.28% of the shares as of September 2025. This significant promoter stake suggests a strong alignment of interests between management and shareholders, which can enhance investor confidence. Public ownership accounted for 37.72%, indicating a healthy distribution of shares among retail investors. The number of shareholders has steadily increased from 3,871 in December 2022 to 4,552 by September 2025, reflecting growing interest in the company. However, the absence of foreign institutional investors (FIIs) may limit the stock’s liquidity and broader market appeal. The consistent promoter holdings and increasing public participation are positive indicators of confidence in the company’s growth prospects, yet the lack of institutional backing could pose challenges in attracting larger investments.
Outlook, Risks, and Final Insight
Looking ahead, Bhaskar Agrochemicals has the potential for continued growth, particularly given the projected sales increase to ₹91 Cr by March 2025. However, challenges remain, including managing the cash conversion cycle and maintaining operational profitability amidst market fluctuations. The company’s strong ROE and ROCE indicate effective management of equity and capital, but the rising CCC poses risks to liquidity. Additionally, the absence of institutional investment could hinder capital raising efforts for expansion. Strengths include solid promoter backing and a growing shareholder base, which can provide stability. In contrast, the company must address operational inefficiencies and liquidity concerns to sustain growth. Overall, Bhaskar Agrochemicals is well-positioned in a growing sector, but it must navigate inherent risks to realize its full potential in the competitive agrochemicals market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,161 Cr. | 964 | 2,114/955 | 12.3 | 487 | 0.62 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 798 Cr. | 236 | 391/165 | 16.4 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 58.6 Cr. | 112 | 149/56.6 | 10.5 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,812 Cr. | 217 | 331/198 | 106 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 699 Cr. | 19.7 | 35.8/16.3 | 54.6 | 22.8 | 1.02 % | 12.9 % | 9.95 % | 1.00 |
| Industry Average | 10,172.95 Cr | 1,061.72 | 29.01 | 369.04 | 0.46% | 15.21% | 19.87% | 6.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.21 | 16.90 | 11.09 | 7.33 | 29.55 | 20.29 | 9.48 | 11.66 | 32.24 | 24.30 | 22.31 | 23.20 | 40.45 |
| Expenses | 19.56 | 14.18 | 11.92 | 9.19 | 24.27 | 17.25 | 9.87 | 13.18 | 26.89 | 20.91 | 20.49 | 22.47 | 35.15 |
| Operating Profit | 3.65 | 2.72 | -0.83 | -1.86 | 5.28 | 3.04 | -0.39 | -1.52 | 5.35 | 3.39 | 1.82 | 0.73 | 5.30 |
| OPM % | 15.73% | 16.09% | -7.48% | -25.38% | 17.87% | 14.98% | -4.11% | -13.04% | 16.59% | 13.95% | 8.16% | 3.15% | 13.10% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 | 0.00 | 0.01 |
| Interest | 0.41 | 0.44 | 0.47 | 0.48 | 0.46 | 0.46 | 0.47 | 0.44 | 0.37 | 0.45 | 0.74 | 0.48 | 0.42 |
| Depreciation | 0.30 | 0.30 | 0.31 | 0.36 | 0.41 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.45 | 0.43 | 0.46 |
| Profit before tax | 2.94 | 1.98 | -1.61 | -2.70 | 4.41 | 2.18 | -1.23 | -2.36 | 4.55 | 2.51 | 0.69 | -0.18 | 4.43 |
| Tax % | 28.91% | 28.79% | -32.92% | -24.81% | 27.66% | 32.11% | -27.64% | -24.15% | 30.33% | 29.08% | -7.25% | 16.67% | 25.96% |
| Net Profit | 2.10 | 1.41 | -1.08 | -2.03 | 3.19 | 1.48 | -0.90 | -1.78 | 3.17 | 1.77 | 0.74 | -0.21 | 3.28 |
| EPS in Rs | 4.03 | 2.71 | -2.07 | -3.90 | 6.12 | 2.84 | -1.73 | -3.42 | 6.08 | 3.40 | 1.42 | -0.40 | 6.30 |
Last Updated: January 9, 2026, 8:07 am
Below is a detailed analysis of the quarterly data for Bhaskar Agrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 40.45 Cr.. The value appears strong and on an upward trend. It has increased from 23.20 Cr. (Jun 2025) to 40.45 Cr., marking an increase of 17.25 Cr..
- For Expenses, as of Sep 2025, the value is 35.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.47 Cr. (Jun 2025) to 35.15 Cr., marking an increase of 12.68 Cr..
- For Operating Profit, as of Sep 2025, the value is 5.30 Cr.. The value appears strong and on an upward trend. It has increased from 0.73 Cr. (Jun 2025) to 5.30 Cr., marking an increase of 4.57 Cr..
- For OPM %, as of Sep 2025, the value is 13.10%. The value appears strong and on an upward trend. It has increased from 3.15% (Jun 2025) to 13.10%, marking an increase of 9.95%.
- For Other Income, as of Sep 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.42 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.48 Cr. (Jun 2025) to 0.42 Cr., marking a decrease of 0.06 Cr..
- For Depreciation, as of Sep 2025, the value is 0.46 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.43 Cr. (Jun 2025) to 0.46 Cr., marking an increase of 0.03 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.43 Cr.. The value appears strong and on an upward trend. It has increased from -0.18 Cr. (Jun 2025) to 4.43 Cr., marking an increase of 4.61 Cr..
- For Tax %, as of Sep 2025, the value is 25.96%. The value appears to be increasing, which may not be favorable. It has increased from 16.67% (Jun 2025) to 25.96%, marking an increase of 9.29%.
- For Net Profit, as of Sep 2025, the value is 3.28 Cr.. The value appears strong and on an upward trend. It has increased from -0.21 Cr. (Jun 2025) to 3.28 Cr., marking an increase of 3.49 Cr..
- For EPS in Rs, as of Sep 2025, the value is 6.30. The value appears strong and on an upward trend. It has increased from -0.40 (Jun 2025) to 6.30, marking an increase of 6.70.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 26 | 28 | 28 | 52 | 52 | 52 | 64 | 62 | 55 | 67 | 91 | 110 |
| Expenses | 26 | 25 | 26 | 26 | 50 | 49 | 49 | 61 | 57 | 50 | 61 | 81 | 99 |
| Operating Profit | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 5 | 5 | 6 | 9 | 11 |
| OPM % | 5% | 5% | 7% | 8% | 4% | 6% | 6% | 5% | 8% | 9% | 9% | 10% | 10% |
| Other Income | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 7 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 44% | 88% | 34% | 28% | |
| Net Profit | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 2 | 4 | 6 |
| EPS in Rs | 2.63 | 2.02 | 3.03 | 1.65 | 0.75 | 1.38 | 1.17 | 1.63 | 2.09 | 0.44 | 3.34 | 7.49 | 10.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 100.00% | -50.00% | -100.00% | 0.00% | 0.00% | 0.00% | -100.00% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -150.00% | -50.00% | 100.00% | 0.00% | 0.00% | -100.00% | 200.00% |
Bhaskar Agrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 45% |
| 3 Years: | 40% |
| TTM: | 175% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 55% |
| 3 Years: | 43% |
| 1 Year: | 70% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: February 1, 2026, 2:27 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | -4 | -3 | -2 | 2 | 3 | 4 | 4 | 5 | 7 | 7 | 9 | 13 | 16 |
| Borrowings | 7 | 6 | 10 | 8 | 12 | 13 | 11 | 11 | 16 | 18 | 18 | 20 | 15 |
| Other Liabilities | 5 | 6 | 5 | 5 | 7 | 9 | 9 | 11 | 16 | 17 | 18 | 20 | 43 |
| Total Liabilities | 13 | 14 | 18 | 21 | 27 | 31 | 30 | 32 | 44 | 47 | 50 | 58 | 79 |
| Fixed Assets | 8 | 9 | 9 | 14 | 14 | 19 | 18 | 18 | 17 | 17 | 18 | 19 | 19 |
| CWIP | 0 | 0 | 4 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 5 | 5 | 6 | 6 | 9 | 12 | 11 | 13 | 27 | 30 | 31 | 40 | 59 |
| Total Assets | 13 | 14 | 18 | 21 | 27 | 31 | 30 | 32 | 44 | 47 | 50 | 58 | 79 |
Below is a detailed analysis of the balance sheet data for Bhaskar Agrochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 3.00 Cr..
- For Borrowings, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 20.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 43.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.00 Cr. (Mar 2025) to 43.00 Cr., marking an increase of 23.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 79.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 58.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 21.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 19.00 Cr..
- For Total Assets, as of Sep 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 21.00 Cr..
Notably, the Reserves (16.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.00 | -5.00 | -8.00 | -6.00 | -10.00 | -10.00 | -8.00 | -8.00 | -11.00 | -13.00 | -12.00 | -11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3 | 7 | 10 | 7 | 8 | 20 | 38 | 20 | 76 | 111 | 82 | 86 |
| Inventory Days | 66 | 73 | 73 | 97 | 65 | 75 | 48 | 66 | 109 | 114 | 142 | 133 |
| Days Payable | 51 | 65 | 34 | 39 | 28 | 34 | 30 | 71 | 91 | 108 | 97 | 64 |
| Cash Conversion Cycle | 18 | 15 | 49 | 65 | 45 | 61 | 56 | 15 | 95 | 116 | 128 | 155 |
| Working Capital Days | -16 | -19 | -28 | -43 | -31 | -39 | -36 | -17 | 4 | 6 | 22 | 26 |
| ROCE % | 20% | 14% | 17% | 12% | 8% | 10% | 9% | 11% | 17% | 12% | 15% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | 2202 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Diluted EPS (Rs.) | 7.48 | 3.34 | 0.45 | 2.09 | 1.63 |
| Cash EPS (Rs.) | 10.82 | 6.40 | 2.77 | 4.26 | 3.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 34.07 | 26.58 | 23.22 | 22.71 | 19.69 |
| Revenue From Operations / Share (Rs.) | 173.73 | 128.21 | 106.30 | 125.72 | 122.77 |
| PBDIT / Share (Rs.) | 17.54 | 11.74 | 9.18 | 9.99 | 6.18 |
| PBIT / Share (Rs.) | 14.21 | 8.70 | 6.86 | 7.82 | 4.21 |
| PBT / Share (Rs.) | 10.37 | 5.10 | 3.57 | 3.74 | 1.63 |
| Net Profit / Share (Rs.) | 7.48 | 3.35 | 0.45 | 2.09 | 1.63 |
| PBDIT Margin (%) | 10.09 | 9.16 | 8.63 | 7.94 | 5.03 |
| PBIT Margin (%) | 8.17 | 6.78 | 6.44 | 6.22 | 3.43 |
| PBT Margin (%) | 5.96 | 3.98 | 3.36 | 2.97 | 1.33 |
| Net Profit Margin (%) | 4.30 | 2.61 | 0.42 | 1.66 | 1.33 |
| Return on Networth / Equity (%) | 21.95 | 12.60 | 1.94 | 9.21 | 8.29 |
| Return on Capital Employeed (%) | 29.23 | 19.67 | 18.20 | 23.01 | 14.20 |
| Return On Assets (%) | 6.67 | 3.48 | 0.49 | 2.47 | 2.69 |
| Long Term Debt / Equity (X) | 0.18 | 0.25 | 0.23 | 0.15 | 0.28 |
| Total Debt / Equity (X) | 1.07 | 1.09 | 1.29 | 1.12 | 0.74 |
| Asset Turnover Ratio (%) | 1.67 | 1.37 | 1.21 | 1.73 | 2.09 |
| Current Ratio (X) | 1.20 | 0.58 | 1.03 | 1.02 | 0.81 |
| Quick Ratio (X) | 0.65 | 0.58 | 0.61 | 0.51 | 0.24 |
| Inventory Turnover Ratio (X) | 0.00 | 7.97 | 3.24 | 4.73 | 7.71 |
| Interest Coverage Ratio (X) | 4.56 | 3.27 | 2.80 | 3.78 | 2.39 |
| Interest Coverage Ratio (Post Tax) (X) | 2.95 | 1.93 | 1.14 | 2.34 | 1.63 |
| Enterprise Value (Cr.) | 60.74 | 48.27 | 55.23 | 49.51 | 26.33 |
| EV / Net Operating Revenue (X) | 0.67 | 0.72 | 0.99 | 0.75 | 0.41 |
| EV / EBITDA (X) | 6.65 | 7.91 | 11.58 | 9.54 | 8.20 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| Price / BV (X) | 2.29 | 2.22 | 3.09 | 2.81 | 1.63 |
| Price / Net Operating Revenue (X) | 0.44 | 0.46 | 0.67 | 0.50 | 0.26 |
| EarningsYield | 0.09 | 0.05 | 0.01 | 0.03 | 0.05 |
After reviewing the key financial ratios for Bhaskar Agrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.34 (Mar 24) to 7.48, marking an increase of 4.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.82. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 10.82, marking an increase of 4.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.07. It has increased from 26.58 (Mar 24) to 34.07, marking an increase of 7.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 173.73. It has increased from 128.21 (Mar 24) to 173.73, marking an increase of 45.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.54. This value is within the healthy range. It has increased from 11.74 (Mar 24) to 17.54, marking an increase of 5.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.21. This value is within the healthy range. It has increased from 8.70 (Mar 24) to 14.21, marking an increase of 5.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 10.37, marking an increase of 5.27.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 3.35 (Mar 24) to 7.48, marking an increase of 4.13.
- For PBDIT Margin (%), as of Mar 25, the value is 10.09. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 10.09, marking an increase of 0.93.
- For PBIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from 6.78 (Mar 24) to 8.17, marking an increase of 1.39.
- For PBT Margin (%), as of Mar 25, the value is 5.96. This value is below the healthy minimum of 10. It has increased from 3.98 (Mar 24) to 5.96, marking an increase of 1.98.
- For Net Profit Margin (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has increased from 2.61 (Mar 24) to 4.30, marking an increase of 1.69.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 21.95, marking an increase of 9.35.
- For Return on Capital Employeed (%), as of Mar 25, the value is 29.23. This value is within the healthy range. It has increased from 19.67 (Mar 24) to 29.23, marking an increase of 9.56.
- For Return On Assets (%), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.67, marking an increase of 3.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.18, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.07. This value exceeds the healthy maximum of 1. It has decreased from 1.09 (Mar 24) to 1.07, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.67. It has increased from 1.37 (Mar 24) to 1.67, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 1.5. It has increased from 0.58 (Mar 24) to 1.20, marking an increase of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.65, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 7.97 (Mar 24) to 0.00, marking a decrease of 7.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.56. This value is within the healthy range. It has increased from 3.27 (Mar 24) to 4.56, marking an increase of 1.29.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has increased from 1.93 (Mar 24) to 2.95, marking an increase of 1.02.
- For Enterprise Value (Cr.), as of Mar 25, the value is 60.74. It has increased from 48.27 (Mar 24) to 60.74, marking an increase of 12.47.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.67, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 25, the value is 6.65. This value is within the healthy range. It has decreased from 7.91 (Mar 24) to 6.65, marking a decrease of 1.26.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 2.29, marking an increase of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.44, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhaskar Agrochemicals Ltd:
- Net Profit Margin: 4.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.23% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.95% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.5 (Industry average Stock P/E: 29.01)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | D. No.1-90/C, Office Unit-608,1T06, 6th Floor. Gowra Fountain Head, Hyderabad Telangana 500081 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. P Pattabhi Rama Rao | Chairman & Managing Director |
| Mr. P Praveen Kumar | Joint Managing Director & CFO |
| Dr. Aluri Naga Uma Maheswara Prasad | Non Executive Director |
| Mrs. P Rajyalaxmi | Non Executive Director |
| Mr. S V Satyanarayana Chowdary | Independent Director |
| Mr. Sudhakar | Independent Director |
FAQ
What is the intrinsic value of Bhaskar Agrochemicals Ltd?
Bhaskar Agrochemicals Ltd's intrinsic value (as of 02 February 2026) is ₹117.39 which is 4.81% higher the current market price of ₹112.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹58.6 Cr. market cap, FY2025-2026 high/low of ₹149/56.6, reserves of ₹16 Cr, and liabilities of ₹79 Cr.
What is the Market Cap of Bhaskar Agrochemicals Ltd?
The Market Cap of Bhaskar Agrochemicals Ltd is 58.6 Cr..
What is the current Stock Price of Bhaskar Agrochemicals Ltd as on 02 February 2026?
The current stock price of Bhaskar Agrochemicals Ltd as on 02 February 2026 is ₹112.
What is the High / Low of Bhaskar Agrochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bhaskar Agrochemicals Ltd stocks is ₹149/56.6.
What is the Stock P/E of Bhaskar Agrochemicals Ltd?
The Stock P/E of Bhaskar Agrochemicals Ltd is 10.5.
What is the Book Value of Bhaskar Agrochemicals Ltd?
The Book Value of Bhaskar Agrochemicals Ltd is 40.0.
What is the Dividend Yield of Bhaskar Agrochemicals Ltd?
The Dividend Yield of Bhaskar Agrochemicals Ltd is 0.00 %.
What is the ROCE of Bhaskar Agrochemicals Ltd?
The ROCE of Bhaskar Agrochemicals Ltd is 21.3 %.
What is the ROE of Bhaskar Agrochemicals Ltd?
The ROE of Bhaskar Agrochemicals Ltd is 24.7 %.
What is the Face Value of Bhaskar Agrochemicals Ltd?
The Face Value of Bhaskar Agrochemicals Ltd is 10.0.